资讯
Univariate and multivariate Cox-regression analyses identified risk factors for OS and RFS. Additional comparisons were made with outcomes in patients with uninodular large HCC (single nodule > 5 cm; ...
According to DelveInsight's analysis, the intermediate AMD market size is anticipated to grow with a significant CAGR during ...
The addition of lenvatinib and pembrolizumab to transarterial chemoembolization extended PFS for patients with intermediate-stage hepatocellular carcinoma, according to randomized phase 3 study ...
Meeting Coverage > ESMO Another Possible Treatment Option for Intermediate-Stage Liver Cancer — Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS by ...
PURPOSE: To investigate whether treatment results in intermediate-stage Hodgkin’s lymphoma can be improved by rapid application of non–cross-resistant drugs, the 10-drug regimen cyclophosphamide, ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果